Answers are grounded in this paper and cite their sources.
A systematic review reveals high economic costs of prostate cancer, suggesting early detection and equitable access can mitigate expenses.
PC imposes a substantial economic burden on healthcare systems and society, particularly in advanced stages. Policy promoting early detection, risk-adapted treatment, and equitable therapy access may help contain costs. Further research should address the economic impact of emerging diagnostics and minimally invasive interventions.
No takes yet. Share an insight, caveat, or question.
Darbà et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: